Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Robert M. Neer, Claude D. Arnaud, José Zanchetta et al. · New England Journal of Medicine · 2001 · 4.6K citations

Medicine, Endocrinology, Bone Metabolism +16

Vertebral fracture assessment using a semiquantitative technique

Harry K. Genant, Chun‐Ying Wu, Cornelis van Kuijk et al. · Journal of Bone and Mineral Research · 1993 · 3.7K citations

Medicine, Orthopaedic Surgery, Radiology +13

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

Bruce Ettinger · JAMA · 1999 · 3.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with Osteoporosis

B. Lawrence Riggs, Stephen F. Hodgson, W. Michael O’Fallon et al. · New England Journal of Medicine · 1990 · 1.1K citations · Full text

Medicine, Endocrinology, Bone Metabolism +14

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

Robert S. Lindsay, Jeri W. Nieves, Carmelo Formica et al. · The Lancet · 1997 · 755 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16